Page last updated: 2024-08-22

cobaltous chloride and Cancer of Head

cobaltous chloride has been researched along with Cancer of Head in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adkins, DR; Kimple, RJ; Michel, LS; Nickel, KP; Redlich, N; Robinson, AM; Stein, AP; Uppaluri, R; Van Tine, BA; Wheeler, DL1
Hebert, C; Nikitakis, NG; Norris, K; Sauk, JJ; Siavash, H; Stewart, J1
Bockmühl, U; Fuchs, J; Gross, J; Jahnke, V; Kietzmann, T; Machulik, A1
Black, LA; Day, TA; Kibbey, MM; Rosenzweig, SA; Slomiany, MG1

Other Studies

4 other study(ies) available for cobaltous chloride and Cancer of Head

ArticleYear
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
    Cell death & disease, 2018, 01-05, Volume: 9, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Cetuximab; Cobalt; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neuregulin-1; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; RNA Interference; RNA, Small Interfering; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous

2018
Phenotypic switching of VEGF and collagen XVIII during hypoxia in head and neck squamous carcinoma cells.
    Oral oncology, 2003, Volume: 39, Issue:8

    Topics: Acetylcysteine; Androstadienes; Antimutagenic Agents; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Cobalt; Collagen Type XVIII; Enzyme Inhibitors; Head and Neck Neoplasms; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Humans; Imidazoles; MAP Kinase Signaling System; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Vascular Endothelial Growth Factor A; Wortmannin

2003
Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
    International journal of oncology, 2005, Volume: 27, Issue:3

    Topics: Acetylcysteine; Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Cell Shape; Cobalt; Deferoxamine; DNA-Binding Proteins; Flow Cytometry; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Necrosis; Nuclear Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription Factors

2005
IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
    Biochemical and biophysical research communications, 2006, Apr-14, Volume: 342, Issue:3

    Topics: Autocrine Communication; Carcinoma, Squamous Cell; Cell Cycle; Cobalt; Culture Media, Conditioned; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Mitogen-Activated Protein Kinases; Models, Biological; Phosphatidylinositol 3-Kinases; Receptor, IGF Type 1; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Transcriptional Activation; Vascular Endothelial Growth Factor A

2006